Soluble endostatin is a novel inhibitor of epithelial repair in idiopathic pulmonary fibrosis

Thorax

Volumn 64, Issue 2, 2009, Pages 156-161

  Richter, A G ^a   McKeown, S ^b   Rathinam, S ^d   Harper, L ^a   Rajesh, P ^d   McAuley, D F ^b   Heljasvaara, R ^c   Thickett, D R ^a,e  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c UNIVERSITY OF OULU   (Finland)

^d UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^e Nuffield House ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; CASPASE; ENDOSTATIN; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FAS LIGAND; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STROMELYSIN; ANGIOGENESIS INHIBITOR; CYTOKINE;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL TYPE 2; LUNG LAVAGE; MALE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; TISSUE REPAIR; WOUND HEALING; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; EPITHELIUM; EPITHELIUM CELL; LUNG ALVEOLUS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; VITAL CAPACITY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; APOPTOSIS; BRONCHOALVEOLAR LAVAGE FLUID; CELL SURVIVAL; CYTOKINES; ENDOSTATINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; EPITHELIUM; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; MATRIX METALLOPROTEINASE 3; MIDDLE AGED; PULMONARY ALVEOLI; VITAL CAPACITY; WOUND HEALING;

EID: 60549105237     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2008.102814     Document Type: Article

References (31)

1. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161:646-64.
2. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134:136-51.
3. Selman M, Pardo A. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir Res 2002;3:3.
4. Uhal BD, Joshi I, Hughes WF, et al. Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am J Physiol 1998;275:L1192-9.
5. Wang R, Ibarra-Sunga 0, Verlinski L, et al. Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol 2000;279:L143-51.
6. Thickett DR, Poole AR, Millar AB. The balance between collagen synthesis and degradation in diffuse lung disease. Sarcoidosis Vasc Diffuse Lung Dis 2001;18:27-33.
7. Felbor U, Dreier L, Bryant RA, et al. Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J 2000;19:1187-94.
8. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88:277-85.
9. Sumi M, Satoh H, Kagohashi K, et al. Increased serum levels of endostatin in patients with idiopathic pulmonary fibrosis. J Clin Lab Anal 2005;19:146-9.
10. Wickstrom SA, Veikkola T, Rehn M, et al. Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells. Cancer Res 2001;61:6511-16.
11. Dhanabal M, Ramchandran R, Waterman MJ, et al. Endostatin induces endothelial cell apoptosis. J Biol Chem 1999;274:11721-6.
12. Wickstrom SA, Alitalo K, Keski-0ja J. Endostatin associates with integrin alpha5beta1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells. Cancer Res 2002;62:5580-9.
13. Hajitou A, Grignet C, Devy L, et al. The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells. FASEB J 2002;16:1802-4.
14. Lee JW, Juliano RL. Alpha5beta1 integrin protects intestinal epithelial cells from apoptosis through a phosphatidylinositol 3-kinase and protein kinase B-dependent pathway. Mol Biol Cell 2000;11:1973-87.
15. Brown KR, England KM, Goss KL, et al. VEGF induces airway epithelial cell proliferation in human fetal lung in vitro. Am J Physiol Lung Cell Mol Physiol 2001;281:L1001-10.
16. Lijnen HR. Matrix metalloproteinases and cellular fibrinolytic activity. Biochemistry (Mosc) 2002;67:92-8.
17. Heljasvaara R, Nyberg P, Luostarinen J, et al. Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases. Exp Cell Res 2005;307:292-304.
18. Abdollahi A, Hahnfeldt P, Maercker C, et al. Endostatin's antiangiogenic signaling network. Mol Cell 2004;13:649-63.
19. Keane MP, Arenberg DA, Lynch JP III, et al. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 1997;159:1437-43.
20. Thickett DR, Armstrong L, Millar AB. A role for vascular endothelial growth factor in acute and resolving lung injury. Am J Respir Crit Care Med 2002;166:1332-7.
21. Young KR Jr, Rankin JA, Naegel GP, et al. Bronchoalveolar lavage cells and proteins in patients with the acquired immunodeficiency syndrome. An immunologic analysis. Ann Intern Med 1985;103:522-33.
22. Roberts JR, Perkins GD, Fujisawa T, et al. Vascular endothelial growth factor promotes physical wound repair and is anti-apoptotic in primary distal lung epithelial and A549 cells. Crit Care Med 2007;35:2164-70.
23. Witherden IR, Tetley TD. Isolation and culture of human type II pneumocytes. In: Rogers DF, Donnelly LE, eds. Human airway inflammation: sampling techniques and analytical protocols. Totowa.: Humana Press Inc, 2001:127-36.
24. Zatterstrom UK, Felbor U, Fukai N, et al. Collagen XVIII/endostatin structure and functional role in angiogenesis. Cell Struct Funct 2000;25:97-101.
25. Yang IV, Burch LH, Steele MP, et al. Gene expression profiling of familial and sporadic interstitial pneumonia. Am J Respir Crit Care Med 2007;175:45-54.
26. Matute-Bello G, Wurfel MM, Lee JS, et al. Essential role of MMP-12 in fas-induced lung fibrosis. Am J Respir Cell Mol Biol 2007;37:210-21.
27. Deininger MH, Wybranietz WA, Graepler FT, et al. Endothelial endostatin release is induced by general cell stress and modulated by the nitric oxide/cGMP pathway. FASEB J 2003;17:1267-76.
28. Dixelius J, Larsson H, Sasaki T, et al. Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis. Blood 2000;95:3403-11.
29. Eriksson K, Magnusson P, Dixelius J, et al. Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways. FEBS Lett 2003;536:19-24.
30. Wickstrom SA, Alitalo K, Keski-0ja J. Endostatin associates with lipid rafts and induces reorganization of the actin cytoskeleton via down-regulation of RhoA activity. J Biol Chem 2003;278:37895-901.
31. Hanai J, Gloy J, Karumanchi SA, et al. Endostatin is a potential inhibitor of Wnt signaling. J Cell Biol 2002;158:529-39.